Literature DB >> 22956143

Utilizing antagomiR (antisense microRNA) to knock down microRNA in murine bone marrow cells.

Chinavenmeni S Velu1, H Leighton Grimes.   

Abstract

MicroRNAs (miRNAs) are highly conserved small RNAs which regulate gene expression primarily through base pairing to the 3' untranslated region of target messenger RNA (mRNA), leading to mRNA degradation or translation inhibition depending on the complementarity between the miRNA and target mRNA. Single miRNA regulates multiple target mRNA. miRNAs have been shown to regulate gene expression in the hematopoietic stem cells, as well as at key decision points for various lineages. However, aberrant expression of miRNAs has been documented in cancer and disease models. Rigorous dissection of miRNA pathways and biology requires facile loss of function modeling. This chapter describes detailed protocol for knockdown miRNA-21 which is involved in myelopoiesis using antagomiRs in primary murine bone marrow stem/progenitor cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22956143      PMCID: PMC4025929          DOI: 10.1007/978-1-62703-008-3_15

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  15 in total

1.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

Review 2.  miRBase: the microRNA sequence database.

Authors:  Sam Griffiths-Jones
Journal:  Methods Mol Biol       Date:  2006

Review 3.  Regulation of microRNA by antagomirs: a new class of pharmacological antagonists for the specific regulation of gene function?

Authors:  Joerg Mattes; Ming Yang; Paul S Foster
Journal:  Am J Respir Cell Mol Biol       Date:  2006-08-17       Impact factor: 6.914

4.  Conditions of appreciable influence of microRNA on a large number of target mRNAs.

Authors:  Vladimir P Zhdanov
Journal:  Mol Biosyst       Date:  2009-04-20

5.  Stable knockdown of microRNA in vivo by lentiviral vectors.

Authors:  Bernhard Gentner; Giulia Schira; Alice Giustacchini; Mario Amendola; Brian D Brown; Maurilio Ponzoni; Luigi Naldini
Journal:  Nat Methods       Date:  2008-11-30       Impact factor: 28.547

Review 6.  Pharmacology of antisense oligonucleotide inhibitors of protein expression.

Authors:  S R Cooper; J K Taylor; L J Miraglia; N M Dean
Journal:  Pharmacol Ther       Date:  1999 May-Jun       Impact factor: 12.310

Review 7.  MicroRNA signatures in human cancers.

Authors:  George A Calin; Carlo M Croce
Journal:  Nat Rev Cancer       Date:  2006-11       Impact factor: 60.716

8.  Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice.

Authors:  Phong Trang; Jason F Wiggins; Christopher L Daige; Chris Cho; Michael Omotola; David Brown; Joanne B Weidhaas; Andreas G Bader; Frank J Slack
Journal:  Mol Ther       Date:  2011-03-22       Impact factor: 11.454

9.  MicroRNAs modulate hematopoietic lineage differentiation.

Authors:  Chang-Zheng Chen; Ling Li; Harvey F Lodish; David P Bartel
Journal:  Science       Date:  2003-12-04       Impact factor: 47.728

10.  Gfi1 regulates miR-21 and miR-196b to control myelopoiesis.

Authors:  Chinavenmeni S Velu; Avinash M Baktula; H Leighton Grimes
Journal:  Blood       Date:  2009-03-10       Impact factor: 22.113

View more
  11 in total

1.  Therapeutic antagonists of microRNAs deplete leukemia-initiating cell activity.

Authors:  Chinavenmeni S Velu; Aditya Chaubey; James D Phelan; Shane R Horman; Mark Wunderlich; Monica L Guzman; Anil G Jegga; Nancy J Zeleznik-Le; Jianjun Chen; James C Mulloy; Jose A Cancelas; Craig T Jordan; Bruce J Aronow; Guido Marcucci; Balkrishen Bhat; Brian Gebelein; H Leighton Grimes
Journal:  J Clin Invest       Date:  2013-12-16       Impact factor: 14.808

2.  MicroRNAs and cancer: Key paradigms in molecular therapy.

Authors:  Weige Tan; Bodu Liu; Shaohua Qu; Gehao Liang; Wei Luo; Chang Gong
Journal:  Oncol Lett       Date:  2017-12-19       Impact factor: 2.967

3.  Next generation miRNA inhibition using short anti-seed PNAs encapsulated in PLGA nanoparticles.

Authors:  Shipra Malik; Jihoon Lim; Frank J Slack; Demetrios T Braddock; Raman Bahal
Journal:  J Control Release       Date:  2020-08-21       Impact factor: 9.776

4.  Dysregulated expression of microRNAs and mRNAs in myocardial infarction.

Authors:  Yaping Wang; Xiaohong Pan; Youqi Fan; Xinyang Hu; Xianbao Liu; Meixiang Xiang; Jian'an Wang
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060

5.  Hormonal regulation of microRNA expression dynamics in the gut of the yellow fever mosquito Aedes aegypti.

Authors:  Xiufeng Zhang; Alexander S Raikhel
Journal:  RNA Biol       Date:  2020-12-23       Impact factor: 4.652

Review 6.  The Role of miRNAs in Angiogenesis, Invasion and Metabolism and Their Therapeutic Implications in Gliomas.

Authors:  Sasha Beyer; Jessica Fleming; Wei Meng; Rajbir Singh; S Jaharul Haque; Arnab Chakravarti
Journal:  Cancers (Basel)       Date:  2017-07-10       Impact factor: 6.639

7.  Monitoring integrity and localization of modified single-stranded RNA oligonucleotides using ultrasensitive fluorescence methods.

Authors:  Philipp Heissig; Waldemar Schrimpf; Philipp Hadwiger; Ernst Wagner; Don C Lamb
Journal:  PLoS One       Date:  2017-03-09       Impact factor: 3.240

Review 8.  From microRNA functions to microRNA therapeutics: novel targets and novel drugs in breast cancer research and treatment (Review).

Authors:  Roberta Piva; Demetrios A Spandidos; Roberto Gambari
Journal:  Int J Oncol       Date:  2013-08-12       Impact factor: 5.650

9.  Co-administration of Anti microRNA-124 and -137 Oligonucleotides Prevents Hippocampal Neural Stem Cell Loss Upon Non-convulsive Seizures.

Authors:  Pascal Bielefeld; Marijn Schouten; Guido M Meijer; Marit J Breuk; Karlijne Geijtenbeek; Sedef Karayel; Alisa Tiaglik; Anna H Vuuregge; Ruth A L Willems; Diede Witkamp; Paul J Lucassen; Juan M Encinas; Carlos P Fitzsimons
Journal:  Front Mol Neurosci       Date:  2019-02-19       Impact factor: 5.639

Review 10.  Editorial focus: understanding off-target effects as the key to successful RNAi therapy.

Authors:  Rafal Bartoszewski; Aleksander F Sikorski
Journal:  Cell Mol Biol Lett       Date:  2019-12-09       Impact factor: 5.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.